STOCK MARKET BSE NSE

EU agency approves Moderna Covid vaccine site in France

The EMA says these new approved sites are expected to result in an additional 1 to 2 million vials of Moderna’s coronavirus vaccine every month.

Published: 11th June 2021 07:15 PM  |   Last Updated: 11th June 2021 07:15 PM   |  A+A-

A nurse prepares doses of the Moderna COVID-19 vaccine at a vaccination center in Le Cannet, southern France. (Photo | AP)

By Associated Press

LONDON: The European Medicines Agency has approved a new manufacturing site for the Moderna COVID-19 vaccine, in a move that could substantially boost production for the European Union.

In a statement on Friday, the EU drug regulator says it had approved a site in Monts, France, operated by Recipharm. In addition to the new site approval, the EMA authorized several other sites to conduct batch control and testing.

This month, two locations in the U.S. were approved for production of vaccines destined for the 27-nation EU bloc. Any medicines or vaccines authorized for the EU market must first have their production facilities approved by the EMA.

The EMA says these new approved sites are expected to result in an additional 1 to 2 million vials of Moderna’s coronavirus vaccine every month.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

edexworks
flipboard facebook twitter whatsapp